Active Supportive Care and Symptom Management Grants
| PI Name | Organization - Company |
Title |
FOA |
|---|---|---|---|
| Tighiouart, Mourad | Cedars-Sinai Medical Center | Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials | RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability |
| Reese, Jennifer Barsky | Research Inst Of Fox Chase Can Ctr | Addressing Sexual Concerns in Breast Cancer Survivors: RCT of a Novel Couple-Based Intervention | PA-16-160: NIH Research Project Grant |
| Bao, Ting | Sloan-Kettering Inst Can Research | Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT)Trial | PA-18-141: Mechanisms, Models, Measurement, and Management in Pain Research |
| Yennu, Sriram | University Of Tx Md Anderson Can Ctr | A Combination Therapy to Treat Cancer-Related Fatigue | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Schenker, Yael | University Of Pittsburgh At Pittsburgh | A cluster randomized trial of a primary palliative care intervention (CONNECT) for patients with advanced cancer | PA-13-302: Research Project Grant |
| Cheville, Andrea Lynne | Mayo Clinic Rochester | Achieving Equity through SocioCulturally-informed, Digitally-Enabled Cancer Pain managemeNTā (ASCENT) Clinical Trial | RFA-NS-22-002: HEAL Initiative: Advancing Health Equity in Pain Management |
| Mosher, Catherine E | Indiana Univ-Purdue Univ At Indianapolis | Acceptance and Commitment Therapy for Fatigue Interference in Metastatic Breast Cancer | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Salvemini, Daniela | Saint Louis University | A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity | PAR-16-275: Serious Adverse Drug Reaction Research |
| Markey, Mia K | University Of Texas At Austin | 3-D modeling-based decision support for optimizing quality of life following breast reconstruction | PA-13-302: Research Project Grant |